MANH vs. QNT: Manhattan Associates vs. Quantinuum Stock Comparison

Company Profile

Manhattan Associates (MANH) and Quantinuum (QNT) both fall under the Software & Services industry group, but MANH is classified in Software while QNT is classified in IT Services.

Manhattan Associates (MANH) has been public since April 23, 1998, giving it decades of market history across multiple cycles, while Quantinuum (QNT) listed only on June 4, 2026 and lacks comparable through-cycle data.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Quantinuum (QNT) reports a negative beta of -2.69, suggesting inverse market sensitivity over the measurement window. That is uncommon for ordinary equities and can reflect commodity-linked or hedge-like exposure, but it can also come from statistical noise. Manhattan Associates (MANH) has a non-negative beta of 0.82.

Risk-Adjusted Performance

Risk-Return Positioning

Both MANH and QNT need 1-year volatility and 1-year return to plot risk-return positioning.

Risk-Adjusted Metrics

Profitability

Capital efficiency shows on one side only: Manhattan Associates (MANH) earns 83.51% on shareholders’ equity, ranked against its industry; Quantinuum (QNT) has no ROE this period.

Manhattan Associates (MANH) at 18.41% retains a top-quartile share of revenue as profit, ahead of Quantinuum (QNT) at 0.00%, which keeps about the industry-typical share.

Quantinuum (QNT) reports a negative operating margin of -6,939.56%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Manhattan Associates (MANH) reports 26.45%, ranking against industry peers normally.

Profitability Metrics

Growth

Quantinuum (QNT) at 34.61% sits in the top revenue growth quartile, while Manhattan Associates (MANH) at 3.75% is in the bottom quartile, showing a clear gap in revenue momentum.

Only one side can be read here: Manhattan Associates (MANH) reports EPS growth of 2.56%, ranked against its industry; Quantinuum (QNT) has no EPS growth figure this period.

Growth Metrics

Financial Strength

Manhattan Associates (MANH) at 1.07 keeps current ratio within its industry’s typical mid-range, while Quantinuum (QNT) at 15.49 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

Quantinuum (QNT) at 0.01 keeps leverage in the lower industry quartile, while Manhattan Associates (MANH) at 0.26 runs a more typical debt-to-equity mix.

Financial Strength Metrics

Dividends

Neither Manhattan Associates (MANH) nor Quantinuum (QNT) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither Manhattan Associates (MANH) nor Quantinuum (QNT) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

An earnings multiple is available for just one side: Manhattan Associates (MANH) trades at 70.81 times trailing earnings, ranked against its peers, while Quantinuum (QNT) has no P/E ratio this period.

Both look expensive on sales: Manhattan Associates (MANH) at 12.69 sits in the upper P/S ratio quartile, and Quantinuum (QNT) at 441.11 prices even higher, above its industry range.

Measured against book value, both Manhattan Associates (MANH) at 73.12 and Quantinuum (QNT) at 64.89 look expensive — each P/B ratio sits above its industry’s benchmark range.

Valuation Metrics